Distribution of 14C-atrazine following an acute lactational exposure in the Wistar rat

被引:20
作者
Stoker, Tammy E. [1 ]
Cooper, Ralph L. [1 ]
机构
[1] US EPA, Endocrinol Branch, Reprod Toxicol Div, MD 72,NHEERL,Off Res & Dev, Res Triangle Pk, NC 27711 USA
关键词
atrazine; lactation; hypothalamus;
D O I
10.1016/j.reprotox.2007.02.004
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The purpose of the present study was to examine the distribution of atrazine in the lactating dam and suckling neonate following an acute exposure to either 2 or 4 mg/kg C-14-atrazine (C-14-ATR) by gavage. C-14-ATR was administered to the nursing dam on postnatal day 3 by oral gavage. Two and a half hours after exposure of the mother to C-14-ATR, the pups were allowed to nurse for 30 min. At the end of the nursing period, radiolabelled residues of C-14-ATR [or C-14-chlorotriazines (C-14-CITRI)] were measured in the organs and tissues of the perfused dam and in the stomachs and brains of the rat pups. Both the 2 and the 4 mg atrazine treatments resulted in a transfer of approximately 0.007% of C-14-CITRI to the stomach (indicator of milk content) and 0.0002% to the brains of the offspring following the 30-min nursing period. Three hours following the dose of C-14-ATR, there was a distribution of C-14-CITRI to the organs of the dam, with the highest amounts in the liver and kidney (1.1 and 0.3% of the administered dose, respectively). Approximately 0.003% of the administered dose was present in three different brain sections of the dam following both doses of C-14-ATR. The results of this study demonstrate that C-14-CITRI are present in small concentrations in the brain and tissues of the dam (adult female) and provide evidence that atrazine or the metabolites can have direct effects on neuroendrocrine function. The results also provide information for postnatal distribution into the suckling neonate during early lactation. (c) 2007 Published by Elsevier Inc.
引用
收藏
页码:607 / 610
页数:4
相关论文
共 21 条
  • [1] ANDERSON PO, 1991, CLIN PHARMACY, V10, P594
  • [2] METABOLISM OF 2-METHOXY-4-ETHYLAMINO-6-SEC-BUTYLAMINO-S-TRIAZINE BY DAIRY COW AND GOAT
    BAKKE, JE
    ROBBINS, JD
    FEIL, VJ
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1971, 19 (03) : 462 - &
  • [3] BERLIN CM, 1981, OBSTETRICS GYNECO S5, V58, P17
  • [4] Breitzka R L, 1997, J Hum Lact, V13, P155, DOI 10.1177/089033449701300219
  • [5] Effect of atrazine on ovarian function in the rat
    Cooper, RL
    Stoker, TE
    Goldman, JM
    Parrish, MB
    Tyrey, L
    [J]. REPRODUCTIVE TOXICOLOGY, 1996, 10 (04) : 257 - 264
  • [6] Atrazine disrupts the hypothalamic control of pituitary-ovarian function
    Cooper, RL
    Stoker, TE
    Tyrey, L
    Goldman, JM
    McElroy, WK
    [J]. TOXICOLOGICAL SCIENCES, 2000, 53 (02) : 297 - 307
  • [7] Cooper RL, 1998, TOXICOLOGIST, P160
  • [8] FACTORS AFFECTING MAMMARY-TUMOR INCIDENCE IN CHLOROTRIAZINE-TREATED FEMALE RATS - HORMONAL PROPERTIES, DOSAGE, AND ANIMAL STRAIN
    ELDRIDGE, JC
    TENNANT, MK
    WETZEL, LT
    BRECKENRIDGE, CB
    STEVENS, JT
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 : 29 - 36
  • [9] A REVIEW OF DRUG TRANSFER TO THE INFANT BY BREAST-FEEDING - CONCERNS FOR THE DENTIST
    GEORGE, DI
    OTOOLE, TJ
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1983, 106 (02) : 204 - 208
  • [10] HAMBOECK H, 1981, MOL PHARMACOL, V20, P579